The ICD-10 code for Sly Syndrome is E76.2, while the ICD-9 code is 277.5. Sly Syndrome, also known as mucopolysaccharidosis type VII, is a rare genetic disorder characterized by the deficiency of an enzyme called beta-glucuronidase. This enzyme deficiency leads to the accumulation of certain substances in the body, causing various symptoms and complications. Proper diagnosis and management are crucial for individuals with Sly Syndrome.
Sly syndrome, also known as mucopolysaccharidosis type VII (MPS VII), is a rare genetic disorder characterized by a deficiency of the enzyme beta-glucuronidase. This enzyme is responsible for breaking down certain substances in the body called glycosaminoglycans (GAGs). Without sufficient beta-glucuronidase activity, GAGs accumulate in various tissues and organs, leading to a range of symptoms.
In the International Classification of Diseases, 10th Revision (ICD-10), the specific code for Sly syndrome is E76.29. This code falls under the broader category of "Other mucopolysaccharidoses," which encompasses various types of MPS disorders. The ICD-10 code E76.29 allows healthcare professionals to accurately identify and classify patients with Sly syndrome for appropriate diagnosis, treatment, and tracking purposes.
In contrast, the International Classification of Diseases, 9th Revision (ICD-9) does not have a specific code for Sly syndrome. However, it falls under the broader category of "Other specified disorders of carbohydrate transport and metabolism" with the code 271.9. This category includes various metabolic disorders, including certain types of MPS.
It is important for healthcare providers, researchers, and insurance companies to use these specific codes to ensure accurate documentation, appropriate billing, and effective tracking of patients with Sly syndrome. Proper coding helps in monitoring the prevalence and understanding the impact of the disorder, as well as facilitating access to necessary resources and support for affected individuals and their families.